Thus, supported by strong evidence in developmental, evolutionary, and cancer biology, this phylogenetic analysis underscores the importance of evolution-based investigations in the conceptual design of logical and durable therapeutic strategies against the heretofore “undruggable” oncogenic K-RAS-driven pancreatic cancer [73]. Here, KRAS is linked to pancreatic neoplasm.